{
    "eid": "2-s2.0-84994507696",
    "title": "Are fluoxetine's effects due to sigma-1 receptor agonism?",
    "cover-date": "2016-11-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [],
    "authors": [
        "S. T. Safrany"
    ],
    "citedby-count": 7,
    "ref-count": 4,
    "ref-list": [
        "Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?",
        "Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats",
        "Blockade of tau hyperphosphorylation and a\u03b2 1-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c3 1 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease",
        "High-Affinity \u03c31 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Zallaq",
            "affilname": "University of Bahrain",
            "affiliation-country": "Bahrain"
        }
    ],
    "funding": []
}